Blueberries Medical Insider Trading
NEO BBM
7
All Trades
0
Significant
0
Notable
0
Clusters
7
Repeat
Healthcare
Sector
Drug Manufacturers
Industry
$7.4M
Market Cap
0.01 – 0.02
52 Week Range
66K
Avg. Volume
| Company | Insider | Title | Date | Shares | Price | Value | Balance | Increase | Signal |
|---|---|---|---|---|---|---|---|---|---|
| Blueberries Medical | Rodriguez, Guillermo | Director | 04-Aug-26 | 36,463,909 | MN RP | ||||
| Blueberries Medical | Rodriguez, Guillermo | Director | 03-Aug-26 | 36,373,909 | MN RP | ||||
| Blueberries Medical | Rodriguez, Guillermo | Director | 30-Jul-26 | 36,353,909 | MN RP | ||||
| Blueberries Medical | Rodriguez, Guillermo | Director | 12-Feb-26 | 35,844,919 | MN RP | ||||
| Blueberries Medical | Rodriguez, Guillermo | Director | 14-Jan-26 | 35,834,919 | MN RP | ||||
| Blueberries Medical | Rodriguez, Guillermo | Director | 12-Jan-26 | 35,704,919 | MN RP | ||||
| Blueberries Medical | Rodriguez, Guillermo | Director | 29-Dec-25 | 35,689,919 | MN RP |
Blueberries Medical (BBM): Insider trading △ Insider buy
Volume (thousands)
Related Companies to Explore
Company Info
Blueberries Medical Company Description
Blueberries Medical is a company listed on the Canadian NEO exchange under the ticker NEO:BBM. Based on available information, the company operates within the medical or healthcare sector, likely focused on research, development, or distribution of medical products or services. As a publicly listed entity on the NEO exchange, which serves emerging growth companies, Blueberries Medical represents the type of mid-stage venture typically found in Canada’s alternative exchange market.
The company maintains operations within the Canadian regulatory environment and is subject to NEO exchange listing requirements and Canadian securities regulations. Like other companies listed on the NEO exchange, Blueberries Medical operates with the oversight of the Investment Industry Regulatory Organization of Canada. Further specific details regarding the company’s exact business model, product portfolio, revenue streams, or geographic reach would require consultation of current financial filings, press releases, or investor relations materials from the company itself, as reliable public information about this particular organization’s operations and achievements may be limited in broader business databases.
Don’t miss today’s trades
Full access to real-time insider buying data — $8.25/mo, billed annually. Cancel anytime.
